These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11822767)

  • 1. Gemcitabine-induced systemic capillary leak syndrome.
    De Pas T; Curigliano G; Franceschelli L; Catania C; Spaggiari L; de Braud F
    Ann Oncol; 2001 Nov; 12(11):1651-2. PubMed ID: 11822767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report.
    Pulkkanen K; Kataja V; Johansson R
    J Chemother; 2003 Jun; 15(3):287-9. PubMed ID: 12868557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
    Biswas S; Nik S; Corrie PG
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):577-9. PubMed ID: 15630853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-induced chronic systemic capillary leak syndrome.
    Bajwa R; Starr J; Daily K
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28855215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease.
    Casadei Gardini A; Aquilina M; Oboldi D; Lucchesi A; Carloni S; Tenti E; Burgio MA; Amadori D; Frassineti GL
    BMC Cancer; 2013 Nov; 13():542. PubMed ID: 24215543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.
    Baron D; Mayo A; Kluger Y
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):90-1. PubMed ID: 16477934
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].
    Dahan L; Ressiot E; Cournede A; Ries P; Duluc M; Laquiere A; Laugier R; Braguer D; Seitz JF
    Gastroenterol Clin Biol; 2007 Dec; 31(12):1143-5. PubMed ID: 18176375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids.
    Spanos S; Vourliotaki I; Drossitis I; Tsoussis S
    J BUON; 2009; 14(4):728-9. PubMed ID: 20148474
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-induced severe pulmonary toxicity.
    Barlési F; Villani P; Doddoli C; Gimenez C; Kleisbauer JP
    Fundam Clin Pharmacol; 2004 Feb; 18(1):85-91. PubMed ID: 14748759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15.
    Cortesi E; Ramponi S; Corona M; Moscetti L; Grifalchi F; Oliva A; Lembo A; Gasperoni S; Padovani A
    Lung Cancer; 2001; 31(2-3):271-6. PubMed ID: 11165407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veno-occlusive disease of the liver induced by gemcitabine.
    Dobbie M; Hofer S; Oberholzer M; Herrmann R
    Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T
    Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab-induced systemic capillary leak syndrome in a breast cancer patient.
    Zhang F; Yang J; Li Z
    Pathol Oncol Res; 2014 Apr; 20(2):435-7. PubMed ID: 24163290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer.
    Manegold C; Bergman B; Chemaissani A; Dornoff W; Drings P; Kellokumpu-Lehtinen P; Liippo K; Mattson K; van Pawel J; Ricci S; Sederholm C; Stahel RA; Wagenius G; van Walree N; ten Bokkel-Huinink W
    Ann Oncol; 1997 Jun; 8(6):525-9. PubMed ID: 9261520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
    Vander Els NJ; Miller V
    Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.